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Stony coral tissue loss disease (SCTLD) has persisted since 2014 in the Southeast
Florida Coral Reef Ecosystem Conservation Area (Coral ECA) where it was first
discovered. Most of the highly susceptible corals have perished, leaving Montastraea
cavernosa as the most abundant reef-building species with high SCTLD prevalence.
Disease interventions (DI) have been conducted throughout Florida’s Coral Reef to
save the remaining corals and reduce the disease prevalence with varying degrees of
success. The two main treatments were chlorinated (Chl) epoxy and an antibiotic paste.
The antibiotic paste was highly effective in the Florida Keys, but its effectiveness in the
Coral ECA was questionable. Therefore, we compared the effectiveness of the antibiotic
paste and Chl epoxy treatments on M. cavernosa to optimize DI efforts on this species in
the Coral ECA. Significant differences were found between the treatment materials and
applications related to the proportion of quiesced lesions and corals where antibiotic
paste (91.2% success) outperformed Chl epoxy (20% success). By day 351, 50.6%
of the antibiotic paste disease-break tissue was fully healed compared to 2.2% of the
total Chl epoxy-filled disease-break area. During the study, new lesions occurred on
previously treated colonies, as well as colonies not previously treated and new lesion
rates varied through time, indicating revisitation is necessary to eliminate disease. Most
margin treatments failed within the first 9 days, however, most disease-breaks failed
before 44 days. Considering the high treatment success of the antibiotic paste and the
conditional variation of new lesion rates, about 1 month is a good practical re-visitation
time for retreating failures and any new lesions. DI using antibiotic paste is currently
the most effective way to intervene the SCTLD epidemic, but this is only effective as
a stopgap measure while the larger causative agents are identified and remediated.
Conducting DI at a reef-scape scale is time consuming and requires extensive personpower and resources, making it very expensive. But this expense pales in comparison
to the current cost to restore the diversity and live tissue saved with DI. This method
also comes with the risk of introducing antibiotics into coral reef environments, which
may have unintended outcomes.
Keywords: tissue loss disease, white plague, white syndrome, coral disease intervention, amoxicillin, coral
antibiotics, florida’s coral reef, southeast florida coral reef ecosystem conservation area
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in the Southeast Florida Coral Reef Ecosystem Conservation
Area (Coral ECA), similar techniques and the same materials
as Aeby et al. (2015) were employed while laboratory trials
on many other materials occurred. Chl epoxy was ideal to get
started because of easy permitting and material availability. In the
Coral ECA, these treatments had moderate success on Orbicella
spp. (77%) but not for M. cavernosa (<40%) (section 4.2 in
Walker et al., 2020).
Concomitantly, an antibiotic paste was developed by Ocean
Alchemists (CoreRx Base 2b with amoxicillin) for experimental
use to increase DI success because amoxicillin halted SCTLD
progression on D. cylindrus fragments (O’Neil et al., 2018)
and amoxicillin and kanamycin halted disease progression on
M. cavernosa and Meandrina meandrites in aquaria (Aeby et al.,
2019). Once permitted for experimental use, the antibiotic paste
was effective on many species in the lower Keys including 90%
success on M. cavernosa (Neely et al., 2020), but its effectiveness
in the Coral ECA was questionable because antibiotic resistant
genes were recently found in the ECA associated with sewage
outfalls (Griffin et al., 2020). Therefore, we tested the efficacy
(effectiveness) of the antibiotic paste and Chl epoxy treatments
on M. cavernosa to optimize DI efforts on this species in the Coral
ECA where SCTLD was endemic for 5 years. Our results provide
information on treatment success, timing of lesion treatment
failures, new infections, and wound healing, which are used
to provide recommendations to assist others planning future
disease interventions.

INTRODUCTION
Considering the ongoing global COVID-19 pandemic, the
extreme effect of a pathogen without a treatment is more
apparent than ever. While the global human population is reeling
from the COVID-19 virus, the reefs of South Florida continue
battling their own epizootic event. First discovered on MiamiDade reefs in 2014, the novel disease, stony coral tissue loss
disease (SCTLD), rapidly spread across Florida’s Coral Reef
(FCR) and has been found at many locations throughout the
Tropical Western Atlantic (Precht et al., 2016; Alvarez-Filip et al.,
2019; Meiling et al., 2020; Heres et al., 2021; Thome et al.,
2021). In Florida, SCTLD has occurred year-round since 2014
and infected up to 22 of the 45 species of scleractinian corals
found on FCR (Aeby et al., 2019; Meyer et al., 2019) including
several important reef-building species and several classified as
endangered on the International Union for Conservation of
Nature (IUCN)’s Red List.
The Tropical Western Atlantic is a known disease “hotspot”
having 66% of recorded disease events despite hosting only 8%
of the world’s coral reefs (Green and Bruckner, 2000), where
some coral diseases, including tissue loss diseases, persist year
round and affect numerous coral species (Harvell et al., 2009;
Weil et al., 2009; Weil and Rogers, 2011; Muller and van Woesik,
2014; Bruckner, 2015; Weil, 2019). The cause and pathogen(s)
responsible for SCTLD are currently unknown and its distinction
from other tissue loss diseases is challenging, however, a plausible
cause is toxicosis related to a breakdown of the host-symbiont
relationship in the gastrodermis resulting in necrosis and a
bacterial infection (Landsberg et al., 2020; Thome et al., 2021).
SCTLD is highly virulent and able to spread both through
direct contact and through the water column (Aeby et al., 2019;
Landsberg et al., 2020; Muller et al., 2020; Thome et al., 2021).
Spatial epidemiological models have estimated a linear epizootic
spread in Florida of about 100 m d−1 over 3 years (Muller et al.,
2020). Disease presentation and lethality vary greatly between
and among species and regions (Aeby et al., 2019; Voss et al.,
2019). Meandroid colonies (Dendrogyra cylindrus, Dichocoenia
stokesii, Eusmilia fastigiata, and other Meandroid meandrites)
are the most susceptible followed by star corals (e.g., Orbicella
spp., Montastraea cavernosa, Siderastrea siderea) (Aeby et al.,
2019; Sharp et al., 2020; Heres et al., 2021). Therefore, when
SCTLD reaches a new location, it rapidly infects the highly
susceptible species first, but can then remain prevalent a long
time by infecting the less susceptible ones (Sharp et al., 2020;
Thome et al., 2021). Locations where the disease has persisted
for several years resulting in widespread regional declines in
both colony density and live tissue cover (Precht et al., 2016;
Walton et al., 2018; Sharp et al., 2020), like southeast Florida, are
considered endemic.
In 2018, disease interventions (DI) were needed as part of the
response to Florida’s SCTLD outbreak to simultaneously reduce
the pathogen load in the environment and attempt to save the
remaining diseased corals. Aeby et al. (2015) previously reported
successful disease intervention using a mixture of marine epoxy
and chlorine powder (Chl epoxy) to cease black band disease in
Hawaii. Considering the immediate need for disease intervention

Frontiers in Marine Science | www.frontiersin.org

MATERIALS AND METHODS
Site Establishment
Three experimental treatment sites were established in northern
Miami-Dade County in the southern part of the Coral ECA
(Figure 1). Each site was located 1–1.5 km from shore, on the
Broward-Miami Ecoregion Ridge-Shallow habitat (Walker et al.,
2008; Walker, 2012) in about 7 m depth. At these locations, all
visibly infected M. cavernosa colonies were tagged, measured,
photographed, and mapped from a central GPS location by
distance and heading. A floating GPS was used to obtain
coordinates for all treated colonies.
Treatments for each coral were determined by evaluating
the percentage of diseased vs. healthy tissue, number of lesions,
colony location, and size to maintain as much consistency
between treatment types as possible, and to avoid any biases
in the analyses from these factors. Initially, 18 colonies were
treated with Chl epoxy and 22 colonies with antibiotic paste.
On May 6, 2019 at GB1, 23 lesions were treated on 10 colonies
with Chl epoxy and 36 lesions on 14 colonies with antibiotic
paste. At SS1, eight lesions were treated on five colonies with
Chl epoxy and five lesions on four colonies with antibiotic paste.
On May 8, 2019 at SS2, three lesions were treated on three
colonies with Chl epoxy and 11 lesions on four colonies with
antibiotic paste. Upon subsequent visits, newly diseased corals
and treatments were added as they were found, but were kept
independent from statistical analysis regarding success of the two
treatment materials used.
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FIGURE 1 | Map of the M. cavernosa corals at the three northern Miami-Dade County treatment sites. Black dots and gray dots represent corals treated with
antibiotic paste or chlorinated epoxy respectively.

chlorine powder (PoolifeTM Turboshock ) at a ratio of 15 g of
chlorine to approximately 50 mL of Part A epoxy. Equal epoxy
parts (Part A with Chl and Part B) were kept separate and then
mixed underwater before application.

Treatment Materials

R

Two disease intervention treatments were tested, an antibiotic
paste and Chl epoxy. The antibiotic paste was a mixture of
amoxicillin trihydrate from PhytoTechnology Laboratories and a
silicone-based paste labeled Base 2b designed to leach antibiotics
slowly over 36 h (originally from CoreRX Pharma, now Ocean
Alchemists). The Base 2b and amoxicillin were mixed by a
weight ratio of 8:1 (Base 2b: amoxicillin). The resulting antibiotic
paste was thoroughly mixed then spread in an approximate
two-centimeter-thick layer for at least 15 min to allow any
of the ethanol-based preservative in the Base 2b to evaporate.
The antibiotic paste was then transferred to 60 ml cathetertip syringes, with the tips cut to facilitate application, and kept
on ice until use.
The Chl epoxy treatment utilized ZSPAR A-788 Splash
ZoneTM two-part marine epoxy. Part A was premixed with
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Treatment Application
Treatment application consisted of methods outlined in Aeby
et al. (2015). A disease-break [analogous to the “firebreak”
in Aeby et al. (2015)] about 5 cm from the visibly diseased
marginand ∼1 cm deep was created using a hammer and chisel
and a Nemo underwater angle grinder (AG-22-5Li-50) with a
4.5-inch masonry grinding disk to isolate the visually diseased
portion from the rest of the colony (white arrows in Figure 2).
Then the disease margin was smothered with treatment material
covering all visibly infected polyps and the “disease-break” was
filled completely (black arrows in Figure 2). After the initial
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ineffectiveness of Chl epoxy was evident, the remaining Chl
epoxy treatments with active disease were treated with antibiotic
paste, hereafter referred to as mixed treatments. This was done
to test the antibiotic paste treatment on corals with lesions where
Chl epoxy failed. No colonies had mixed treatments at the onset
of the study. Antibiotic paste success on lesions where Chl epoxy
failed would eliminate the possibility of the Chl epoxy lesions
being unique. This resulted in a much greater overall number of
antibiotic paste treatments by the end of the study.

health, disease progression, treatment effectiveness, and healing.
Lesion treatments were considered successful until disease was
observed progressing past the treatment on subsequent visits.
These cases were recorded as treatment failures. Disease-breaks
were considered successful until disease reached and crossed
the disease-break. Percentage success was calculated as 100—
(number of lesion failures/total number of treatments ∗ 100).
Colony treatments were considered successful until one of the
lesion treatments failed. Healing was assessed during the final two
monitoring visits (January 31 and April 21, 2020) by measuring
the length of fully healed tissue along the disease-breaks. To be
considered “fully healed,” the live tissue had to grow over and
make contact across the disease-break. Because all lesions were
treated at every visit, new treatments unrelated to previously
treated lesions were used as a surrogate for new lesions. A daily
infection rate was calculated by dividing the number of new
lesions and corals with new lesions by the number of days
since the last visit.

Monitoring
Corals were initially treated on May 6 and 8, 2019 and revisited
weekly until June 5 [May 15 (day 9), May 21 (day 15), May 29
(day 23), June 5 (day 30)], after which they were revisited on June
19 (day 44), June 27 (day 52), July 10 (day 65), July 30 (day 85),
August 13 (day 99), and October 10, 2019 (day 157), and January
31 (day 270) and April 21, 2020 (day 351). During treatment
and monitoring, high resolution photographs and videos were
taken to record the total coral condition, each treatment, and new
infections. These consisted of whole-colony nadir photographs
and individual treatments taken perpendicularly to the colony
center at a fixed distance away with a standard measuring scale in
the image. We used these photographs to visually assess colony

Statistical Analyses
All statistical analyses were completed using R statistical
software, version 4.0.4 (R Core Team, 2021) and the rstatix
package (Kassambara, 2021). Datasets were not normally

FIGURE 2 | Examples of disease-break application and healing. Disease lesions before treatment are indicated by white arrows and black arrows depict the
disease-breaks. The rows are the same lesions over time showing the lesion before treatment (left), upon treatment (Middle), and sometime after treatment (right).
The top row lesion was treated on May 6, 2019 and showed disease cessation and healing by June 5, 2019 (1 month). Note that the disease-break contained the
spread of the disease where the margin treatment was not effective (right side). The middle row coral was treated on May 15, 2019 and was fully healed by January
31, 2020 (eight and a half months). The bottom row colony was treated on May 19, 2019 and was fully healed on Oct 9, 2019 (5 months).

Frontiers in Marine Science | www.frontiersin.org

4

July 2021 | Volume 8 | Article 666224

Walker et al.

Optimizing SCTLD Disease Intervention Techniques

distributed (Shapiro-Wilk p < 0.05) and required nonparametric methods for determining whether there were
differences between groups (site or treatment application
method). Kruskal-Wallis one-way analysis of variance tests
were used to determine if live colony surface area, number
of initial lesions treated, length of margin or disease-break
treatment, and the percent old and new mortality on each
coral was different between sites or initial treatment application
method. Results of these analyses promoted the grouping of
colonies from all sites by treatment application to evaluate
the differences in success at halting disease by lesions and
pooled by colony.
Fisher’s exact tests and pairwise Fisher’s tests were used
to detect significant differences between the success of both
treatment materials (antibiotic paste and Chl epoxy). For the
purpose of analysis, treatments were considered successful if
the intervention halted disease progression and did not fail
by the end of the monitoring period. Initial lesion treatments
consisted of a margin and a disease-break in combination;
the success of both were assessed independently, and in
combination, to determine if any significant differences in
application method were sequestered to one portion of the
treatment. Additionally, both the lesion and colony treatment
successes were assessed independently in all statistical tests to
determine if disease intervention effectiveness was significantly
different between treatments.
The amount of tissue fully healed along the disease-breaks
was used to assess differences in healing between treatment
materials and application methods. For both treatment types,
the proportion of disease-breaks healed for each coral were
not normal (Shapiro-Wilk p = 1.58−10 ) thus non-parametric
Kruskal-Wallis one-way analysis of variance were used to
determine if differences were significant. A categorical treatmentmonth variable was used to simultaneously assess the change in
healing over time of each treatment, but also the difference in
healing between each treatment material at each time. Pairwise
multiple comparisons were performed on the treatment-month
variable to indicate the level of difference between each treatment
material, at each time.

RESULTS
Statistical assessment indicated that there were very few
significant differences between sites, and any of the tested
coral metrics (Table 1). When pooled by coral, the colony live
surface area, number of lesions treated, margin treatment length,
disease-break length, the percentage of disease, the percent
of old mortality, or the percent of new mortality were not
significantly different between the three sites investigated, or
between the treatment materials (p > 0.05). When analyzed by
lesion, there was a significant difference in disease-break length
between sites (p = 0.01913), but pairwise comparisons failed to
resolve those differences. Additionally, antibiotic paste diseasebreaks were significantly longer than Chl epoxy disease-breaks
(p = 0.02485). However, when pooled by coral, disease-break
length was not significantly different between sites or treatment
materials (p > > 0.05).

Treatment Success
Of the original 41 colonies treated, 34 lesions were treated on
21 colonies with antibiotic paste and 34 lesions on 20 colonies
with Chl epoxy (Table 2). Twenty of the antibiotic paste margin
treatments stopped the disease and 14 failed (58.8% success),
quiescing the disease on 10 colonies (47.6%). All margin failures
led to the disease reaching the disease-break, of which 11 quiesced
the disease and 3 failed (78% success), quiescing the disease on 8
colonies (38.1%). Thus, the antibiotic paste margin and diseasebreak treatment combination succeeded 31 out of 34 times
(91.2% success), quiescing the disease on 18 out of 21 colonies
(85.7%). Conversely, two of the Chl epoxy margin treatments
stopped the disease and 32 failed (5.9% success), quiescing the
disease on 1 colony (5%). All Chl epoxy margin failures led to
the disease reaching the disease-break, of which 6 stopped the
disease and 26 failed (19% success), quiescing the disease on 3
colonies (15%). Therefore, the Chl epoxy margin and diseasebreak treatment combination succeeded 8 out of 34 times (23.5%
success), quiescing the disease on 4 out of 20 colonies (20%).
Significant differences were found between the treatment
materials and applications related to the proportion of quiesced

TABLE 1 | Results of the statistical assessment (Kruskal-Wallis p-values) comparing the variable between sites or treatment materials.
Variable

Lesion

Coral

Site
Live surface area

(cm2 )

Treatment

Site

Treatment

NA

NA

0.349

0.774

Lesions treated (#)

NA

NA

0.139

0.858

Margin length (cm)

0.139

0.061

0.853

0.667

Margin success (%)

0.510

3.631−6 *

0.742

5.662−6 *

Disease-break length (cm)

0.0191*

0.0249*

0.932

0.557

Disease-break success (%)

0.849

0.000132*

0.938

0.00812*

Combo treatment success (%)

0.548

2.168−8 *

0.705

2.939−5 *

Disease (%)

NA

NA

0.102

0.415

Previous mortality (%)

NA

NA

0.861

0.783

Recent mortality (%)

NA

NA

0.135

0.580

*Indicates a significant result.
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0.5000
*Retreatments to previously treated and failed lesions.

0.9091
10

4
8

11
0.9565

0.667
12

22
1

6
18

23

lesions and corals. When analyzed by lesions, antibiotic
paste treatments had a significantly higher proportion of
succeeded margins (Fisher’s p = 0.00083), disease-breaks (Fisher’s
p = 0.0203), and combination treatments (Fisher’s p = 0.00372)
than the Chl epoxy treatments. When pooled by corals,
antibiotic paste treatments had a significantly higher proportion
of succeeded margins (Fisher’s p = 0.0344) and combination
treatments (Fisher’s p = 0.0284) than Chl epoxy, but the difference
in disease-break success was not significant (Fisher’s p = 0.308).
The original treatment failure timing varied between materials
and application (Figure 3). Most of the margin failures (91.3%)
occurred within 9 days of initial treatment, regardless of
treatment material (Figures 3A,C), although the proportion of
antibiotic paste failures was significantly lower than Chl epoxy
failures (Fisher’s p = 0.0169). Very few margin failures occurred
after 9 days (8.7%), and all margins that lasted longer than
44 days did not fail (32.3%). Disease-break failures varied in
timing and occurred over a longer time period (Figures 3B,D).
Chl epoxy disease-breaks failed between 9 and 52 days, with
the majority failing between 23 and 30 days post treatment. At
44 days, 61.8% (21/34) of the chlorinated disease-breaks had
failed. Conversely at 99 days, only 8.8% (3/34) of the antibiotic
disease-breaks had failed.
After the Chl epoxy disease-break failures, those lesion
margins were retreated with antibiotic paste (no disease-breaks)
to test any differences in antibiotic paste treatments between the
corals originally treated with different treatment material. On
day 23, seven Chl epoxy disease-break failures were retreated on
six corals (Table 3). On day 30, seven failures were retreated on
seven corals. On day 44, five failures were retreated on four corals.
On day 65, five failures were retreated on five corals. And on
days 85 and 157, one failure was retreated on one coral. In this
mixed-treatment group, the antibiotic paste successfully halted
disease progression in 21 of 26 lesions (80.8%) on 11 of the 16
colonies (68.8%). The mixed treatment success was significantly
higher than the original Chl epoxy margin treatments (Fisher’s
p = 0.0003) and not different from antibiotic paste margin
treatment success (Fisher’s p > 0.05). The proportion of mixed
treatment corals quiesced by antibiotic paste was not significantly
different to the original antibiotic paste treatments (Fisher’s
p = 1), nor the Chl epoxy treatments (Fisher’s p = 0.44).
None of the antibiotic paste margin treatment failures
quiesced before reaching the disease-break, indicating that the
antibiotics in the disease-breaks offered little, if any, effect to
the success of the margin treatment. Although, the success of
antibiotic paste margin-only treatments on previously untreated
colonies (82.8%) was higher than the antibiotic paste margin
treatment success of the combination treatments (58.8%), this
difference was not significant (Fisher’s p = 0.454) indicating no
effect of the disease-break on margin treatment success.

Margin

Margin
Mixed

Antibiotic paste

Margin
Antibiotic paste

New lesions on previously untreated corals

1.00

0.9231
12
13
0.9697
32
1

0.6875

New lesions on previously treated corals

33

5
5
1.00
17
0
Margin
Antibiotic paste
Original margin only

17

0.2000
4

11
16

0.2353

0.8077
21

8
26

5
26

34

Retreatments*

Combination
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Mixed

0.0500

0.1500
3

1
20

0.1875

0.0588
2

6
26
32

32
34
Margin

Disease-break

0.833
6

Chlorinated epoxy
Original combination

0.5000

0.8571
31
34

Retreatments*

3

5

0.4762

Combination

1

0.9118

2

1

18

8

10
21

0.7857

0.5882
20

11
14

3

34
Margin

Disease-break

Original combination

Antibiotic paste

14

Number
quiesced
Treatment application
Treatment group

Treatment material

Number tested

Number failed

Number
quiesced

Proportion
quiesced

Number
treated

Corals
Lesions
TABLE 2 | Treatment success metrics by treatment group, material, and application.

0.3810
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Proportion
quiesced
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New Lesions
During the study, new lesions occurred on previously treated
colonies, as well as colonies not previously treated (Table 3).
In total, eight additional colonies were treated after site
establishment: three were added on day 15; two on day 23;
and one each on days 44, 85, and 157. Six of the eight
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FIGURE 3 | The proportion of treatments (n = 34 per panel) succeeding at halting the disease following antibiotic (A) disease margin and (B) disease-break
treatments, and chlorinated epoxy (C) disease margin and (D) disease-break treatments over time. The high initial disease-break successes were from the disease
lesions not yet reaching the treatment.
TABLE 3 | Summary of lesion and coral treatments by visitation date.
Corals
Visitation date

New lesions

Total treated

New corals
treated

Retreated

Total treated

New lesions
on new corals

New lesions on
retreated corals

Retreated
lesions

5/6/2019

24

24

0

58

58

0

0

5/8/2019

20

20

0

27

27

0

0

5/15/2019

0

0

0

0

0

0

0

5/21/2019

3

3

0

4

4

0

0

5/29/2019

8

2

6

11

3

8

25

6/5/2019

6

0

6

11

0

11

13

6/19/2019

4

1

3

7

3

4

9

7/10/2019

4

0

4

8

0

8

9

7/30/2019

4

1

3

10

1

9

1

8/13/2019

2

0

2

2

0

2

3

10/10/2019

4

1

3

4

1

3

1

1/31/2020

4

0

4

6

0

6

0

4/21/2020

4

0

4

11

0

11

0

corals were added during May and early June 2019, which
corresponded closely to the peak of new lesions at these sites
during the monitoring.
The number of new lesions also varied through time. No new
lesions were treated for 2 weeks immediately following initial

Frontiers in Marine Science | www.frontiersin.org

treatment, but after 44 days, 33 new lesions had been treated,
with an additional 18 lesions treated in July (Table 3). Whereas,
between August 2019 and January 2020, there were just 12 new
lesions treated. The daily infection rate was highest for corals on
day 23 with 1 newly infected coral per day since last visit, and
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alarming rates, therefore we chose to include more corals per
treatment than to sacrifice some as controls. Thirdly, SCTLD was
thought to be a waterborne pathogen and leaving diseased corals
at the site might affect the treatment results by providing a nearby
source of disease. We do not recommend using Chl epoxy on
M. cavernosa, as it may not be different from taking no action.
There are numerous possible reasons for disease intervention
(DI) treatment failures and the discrepancy of success between
the antibiotic paste and Chl epoxy. First, inconsistent treatment
applications are a recognized problem. The objective is to
cover all bleached and diseased-looking tissue with treatment
material. Neely et al. (2020) found reduced success when paste
was not fully contacted with tissue. Treating M. cavernosa is
especially challenging because of the species’ polyp size and
morphology, tissue thickness, and mucous production. Both
treatment materials adhered well to the M. cavernosa rugose
dead skeleton, but not to the live tissues. This is problematic
because the live tissue at the disease margin is the target of the
treatment. Sometimes the disease margin is too wide for the
application to adhere solely to the dead skeleton at the margin.
The lack of adhesion can lead to an early treatment sloughing,
rendering it ineffective.
Another reason for failures and success discrepancy is
treatment dosing time. The antibiotic paste was formulated to
deliver a high dose of amoxicillin over a 36 h period (Neely
et al., 2020), whereas the Chl epoxy has a short hardening time
(∼2 h) that bounds the chlorine inside rendering it less effective.
A longer exposure time of chlorine may prove more effective,
however there are currently no proven treatment methods
demonstrating this. Chlorine is difficult to administer in a time
release medium as it reacts or dilutes away quickly when exposed
to seawater. Chl epoxy has been found more successful on species
with smaller polyps and thinner tissues where it can smother live
tissue and bind with the skeleton more easily like Orbicella spp.
and Montipora spp. (Aeby et al., 2015; Walker et al., 2020), but
the antibiotic paste is still more effective.
Finally, it is important to ensure a consistent treatment
concentration throughout the treatment material. A thorough
mixing of the active agents into the application material is
critical to ensuring consistent treatment along the disease margin.
Uneven mixing will create portions of application material with
little active ingredients which may allow the disease to progress
after treatment.
Recent studies indicate that some level of natural disease
quiescence can be expected on untreated colonies, but there is
high variation depending on the monitoring time of the study,
location, environmental conditions, and perhaps time of year.
In southeast Florida, Shilling et al. (2021) found that about 40%
of untreated colonies quiesced after 46 weeks, whereas Aeby
et al. (2019) found 60% (12/20) quiesced after 52 weeks. Neely
et al. (2020) found no (0/4) colonies quiesced after 8 weeks in
the Florida Keys, while Meiling et al. (2020) found 20% (1/5)
of colonies quiesced after 22 weeks in St, Thomas, V.I. Meiling
et al. (2020) also reported significant drops in tissue loss rates
during high temperature stress in St. Thomas during the late
summer and fall. In southeast Florida, we found a drop in
new lesion rates without temperature stress during the same

for lesions on day 30 with 1.6 new lesions per day since last visit
(Figure 4). On day 44 these rates dropped to 0.3 corals with new
infections per day and 0.5 new lesions per day since last visit, and
stayed relatively stable until dropping noticeably on Day 99 and
staying low the remainder of the study.
There were no statistical differences in new lesions on corals
receiving different original treatment materials, indicating no
bias between groups of corals. After the original treatments,
colonies in both treatment groups had a similar proportion of
new lesions: 61.9% (13/21) of the antibiotic paste treatment corals
and 55% (11/20) of the mixed treatment corals (Fisher’s p = 1).
However, it is unknown if the Chl epoxy treatment corals would
have had a different proportion of new lesions if they had not
received subsequent antibiotic paste treatments.
The success of new lesion margin treatments on previously
treated corals was very high when analyzed by lesion (96.4%;
54/56) and pooled by coral (91.7%; 22/24) (Table 2). However,
these differences were not significantly higher than the original
margin treatment success analyzed by lesion (Fisher’s p = 0.182)
and pooled by coral (Fisher’s p = 0.239).

Disease-Break Healing
Tissue healing over disease-breaks treated with antibiotic paste
was more frequent than to those treated with Chl epoxy. Of
the original treatments, 90.5% of antibiotic paste-filled diseasebreaks exhibited some tissue regrowth compared to just 15% of
the disease-breaks filled with Chl epoxy. There was a significantly
higher mean proportion of fully healed disease-break area
following treatment with amoxicillin, when compared to Chl
epoxy in both January (Kruskal-Wallis p = 3.6−5 ) and April
(Kruskal-Wallis p = 1.7−5 ) (Figure 5). By day 351, the mean
disease-break area fully healed for antibiotic paste disease-break
treatments was 50.6% (± 7.8%), compared to 2.2% (± 1.9%) for
Chl epoxy-filled disease-breaks.

DISCUSSION
The antibiotic paste used in this study is a highly effective
treatment for SCTLD on M. cavernosa when applied both to
the disease margin and to a disease-break cut into healthy
tissue. Our success rates were consistent with other recent
SCTLD interventions using the same materials. For example,
Neely et al. (2020) found that Base 2b and amoxicillin
margin treatments were 80% effective vs. our result of 82.8%
(29/35) effectiveness of margin only treatments. Shilling et al.
(2021) found 95% quiescence using margin and disease-break
combination treatments vs. 91.2% in this study.
Chlorinated (Chl) epoxy proved far less effective at halting
M. cavernosa SCTLD progression (28.6%). This compared closely
to the 26% of colonies quiesced in Shilling et al. (2021) with
Chl epoxy treatments which were not significantly different than
the untreated control colonies. Our study purposefully did not
include untreated controls for several reasons. First, two other
nearby studies, Aeby et al. (2019) and Shilling et al. (2021), were
monitoring control corals that we could reference. Second, it
was anecdotally recognized that untreated corals were dying at
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FIGURE 4 | Rates are calculated as the number of new lesions (or new corals)/number of days since last assessed. The rate since last visit of new disease lesions
and newly diseased corals. Vertical lines indicate the cumulative number of days elapsed since initial treatments.

antibiotic paste. The timing and frequency of revisiting likely
depends on the treatment method, treatment material, rate of
tissue loss, frequency of new lesions, environmental factors,
season, and perhaps species. Shilling et al. (2021) recommended
revisiting between 2 and 3 months to treat new infections,
however most of our failed margin treatments occurred within
the first 9 days (Figures 3A,C) indicating the optimum revisiting
time was around 10–14 days posttreatment for antibiotic paste
margin treatments. Most of our disease-breaks failed before
44 days, extending the necessary return time to 1.5 months. Yet,
the new lesion rates were highest in June indicating a new lesion
on a coral every day whereas October through May, these rates
were extremely low. Considering the high treatment success of
the antibiotic paste and the conditional variation of new lesion
rates, about 1 month is a good practical re-visitation time for
retreating failures and any new lesions.
When deciding on the use of disease-breaks, the increased
success must be weighed against the increased treatment
application time, materials, coral stress, and healing rates.
Disease-breaks kill the live tissue upon contact, carve a trench
into the coral skeleton, and isolate the tissues nearest to the
disease margin. Aside from local mucus production at the site
during creation, there were no other visible signs of coral stress
from the trenching. However, physically isolating the disease
margin may reduce the colony’s ability to fight the disease and
isolating the margin treatment may inhibit any possible benefits
of the margin treatment antibiotics from reaching other parts of
the colony. This could help explain the lower success of margin
treatments when accompanied with a disease-break (58.8%) vs.
solo margin treatments (82.8%). Although these successes were
not significantly different, the percentage difference is high and
bears consideration.
Regardless of the lower margin success, the combined margin
and disease-break antibiotic paste treatment was the most
effective (91.2%). The high success of the antibiotic paste
margin and disease-break combination makes it a good option,
especially where re-visitation is not planned, the colonies are

FIGURE 5 | The mean proportion of disease-break area that was fully healed
by antibiotic paste and chlorinated epoxy treatments in both months visited.
The letters above the bars indicate statistical differences between treatment
materials during both months visited. Error bars = standard error.

time. Additionally, Shilling et al. (2021) first treated colonies
in April 2019 and reported quiescence in untreated colonies at
14, 23, and 46 weeks (July, September, and February). Meiling
et al. (2020) attributed the slowing of tissue loss to increased
temperature stress, however, the coincidence of the slowing of
disease in southeast Florida during the same time bears additional
investigation. In southeast Florida after monitoring and treating
the same colonies monthly for 1.5 years, Walker et al. (2020)
found that the number of new infections on Orbicella faveolata
colonies varied seasonally with most occurring between June
and September, thus it is possible that disease quiescence also
has temporal patterns. Conducting intervention studies during
different seasons and monitoring for a longer period would
help determine seasonal effects on disease quiescence and new
lesion occurrence.
Frequent monitoring provided information on optimizing
treatment success by capturing the timing of treatment failures
and informing when to retreat colonies. The antibiotic paste
treatment did not prevent subsequent new lesions and the new
lesion rates were similar in each treatment group, indicating
that revisitation is necessary to keep the corals alive using the
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should be employed to target specific disease intervention goals
such as prioritizing specific locations, species, and/or individuals
to save. We encourage others to continue testing new treatments
and addressing other factors affecting coral health. Ideally these
are fast one-time highly effective treatments with materials that
have a low risk of adverse impacts to the corals or other reef
organisms and would heal quickly.

of particularly high value, treatment material is in abundant
supply, and/or disease prevalence is relatively low. However,
creating and treating disease-breaks takes time that may be
better spent treating the margins of other colonies if disease
prevalence is high.
Antibiotic paste disease-breaks showed extensive healing
where the intervention was virtually unnoticeable after 1 year on
many corals (Figure 2). Since 50.6% of the disease-break area
treated with amoxicillin reconnected and fully healed during our
study, it appears tissue isolation was temporary in many cases.
Disease-breaks filled with Chl epoxy were far less likely to yield
tissue regrowth (<5%). It appeared that the permanent presence
of the epoxy and subsequent colonizers hindered the natural coral
wound healing process.
There are environmental concerns that releasing antibiotics
into the ocean may have unintended negative environmental
impacts, like promoting antibiotic resistant bacteria or
slowing coral growth (Sweet et al., 2011; Zhang et al., 2018).
Unfortunately, antibiotics and other pollutants have been
released into the coastal system for many years in southeast
Florida through multiple wastewater ocean outfalls that expel
over 510 million gallons per day of treated effluent (Koopman
et al., 2006). The Miami-Dade Central Wastewater Treatment
Plant located on Virginia Key, releases ∼143 million gallons
of wastewater daily (Koopman et al., 2006). This effluent is
partially treated but still contains nutrients and chemicals
such as hormones and antibiotics (Englehardt et al., 2001).
Recently, multiple antibiotic resistance genes, including ampC
(which bestows amoxicillin resistance), were found year-round
in samples taken from the water column and in the sediments
around outfall pipes (Griffin et al., 2020). There were no observed
impacts of the antibiotic treatments on the treated corals or
surrounding organisms other than stopping the disease lesion
progression (e.g., no fish or invertebrate grazing on material, no
obvious new maladies in surrounding organisms, no new blooms
or mortality). To minimize the risk of developing antibiotic
resistance, we used a highly concentrated dose which killed both
the pathogen and the underlying coral tissue. This dose is less
likely to foster/generate antibiotic resistance than multiple lower
doses designed to boost the coral’s immune response (Roberts
et al., 2008). Although the scale of what is released into the
ocean by the outfalls dwarfs the amounts released in SCTLD
interventions, the negative ecological impacts of antibiotics to
the reef system remains unknown and should be considered in
DI efforts, especially in more pristine locales.
The bottom line is that coral disease interventions can save
corals. These activities are currently the most effective way
to intervene the SCTLD epidemic, but they are only effective
as a stopgap measure while the larger causative agents are
identified and remediated. Conducting DI at a reef-scape scale
(1–10 km2 ) is time consuming and requires extensive personpower and resources, making it very expensive. But this expense
pales in comparison to the current cost to restore the diversity
and live tissue saved with DI. DI also comes with the risk
of introducing antibiotics into coral reef environments, which
may have unintended outcomes (Zhang et al., 2018). Since
interventions are not yet practical at a seascape scale, strategies
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